Down-regulation of Mcl-1 by inhibition of the PI3-K/Akt pathway is required for cell shrinkage-dependent cell death

Takashi Araki, Matsuhiko Hayashi, Naohide Watanabe, Hirotaka Kanuka, Jun Yoshino, Masayuki Miura, Takao Saruta

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

The anti-apoptotic effect of a chloride-bicarbonate exchange blocker has been previously examined in endothelial cells and cardiomyocytes. However, the anti-apoptotic effects of this blocker on epithelial cells and the mechanism of the anti-apoptotic effect remain unknown. We examined the anti-apoptotic effects of a chloride-bicarbonate exchange blocker in a renal epithelial cell line (MDCK cells). Changes in the expression of bcl-2 family proteins, which are known to have anti-apoptotic effects, were also examined. Staurosporine was used to induce apoptotic cell death in the MDCK cells. Staurosporine treatment was sufficient to induce apoptotic cell death, detected by propidium iodide and DNA ladder formation. A chloride-bicarbonate exchange blocker was added 24 h before the staurosporine treatment and during treatment. The chloride-bicarbonate exchange blocker inhibited the staurosporine-induced apoptosis in the MDCK cells in a dose-dependent manner. The expression of bcl-2 family gene products was detected by RT-PCR and Western blotting. No changes in the expression of Bax, Bid and Bik (pro-apoptotic proteins), or Bcl-2 (an anti-apoptotic protein) were detected. However, Mcl-1 expression was reduced by the staurosporine treatment, and this reduction was recovered when the chloride-bicarbonate exchange blocker was added. LY294002, a PI 3-kinase inhibitor, partially inhibited this anti-apoptotic effect. In conclusion, chloride-bicarbonate exchange blockers appear to offer cell-protective effects via Mcl-1 up-regulation.

Original languageEnglish
Pages (from-to)1275-1281
Number of pages7
JournalBiochemical and Biophysical Research Communications
Volume290
Issue number4
DOIs
Publication statusPublished - 2002

Fingerprint

Cell death
Bicarbonates
Staurosporine
Chlorides
Cell Death
Down-Regulation
Madin Darby Canine Kidney Cells
Apoptosis Regulatory Proteins
Epithelial Cells
bcl-2 Genes
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
Propidium
Endothelial cells
Ladders
Phosphatidylinositol 3-Kinases
Cardiac Myocytes
Ion exchange
Up-Regulation
Endothelial Cells
Genes

Keywords

  • 4,4-diisothiocyanatostilbene-2,2-dislufonic acid (DIDS)
  • Apoptosis
  • AVD
  • Mcl-1
  • PI 3-kinase
  • Staurosporine

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Down-regulation of Mcl-1 by inhibition of the PI3-K/Akt pathway is required for cell shrinkage-dependent cell death. / Araki, Takashi; Hayashi, Matsuhiko; Watanabe, Naohide; Kanuka, Hirotaka; Yoshino, Jun; Miura, Masayuki; Saruta, Takao.

In: Biochemical and Biophysical Research Communications, Vol. 290, No. 4, 2002, p. 1275-1281.

Research output: Contribution to journalArticle

Araki, Takashi ; Hayashi, Matsuhiko ; Watanabe, Naohide ; Kanuka, Hirotaka ; Yoshino, Jun ; Miura, Masayuki ; Saruta, Takao. / Down-regulation of Mcl-1 by inhibition of the PI3-K/Akt pathway is required for cell shrinkage-dependent cell death. In: Biochemical and Biophysical Research Communications. 2002 ; Vol. 290, No. 4. pp. 1275-1281.
@article{ecbe9cf6276c4d84ba2c927382c2438a,
title = "Down-regulation of Mcl-1 by inhibition of the PI3-K/Akt pathway is required for cell shrinkage-dependent cell death",
abstract = "The anti-apoptotic effect of a chloride-bicarbonate exchange blocker has been previously examined in endothelial cells and cardiomyocytes. However, the anti-apoptotic effects of this blocker on epithelial cells and the mechanism of the anti-apoptotic effect remain unknown. We examined the anti-apoptotic effects of a chloride-bicarbonate exchange blocker in a renal epithelial cell line (MDCK cells). Changes in the expression of bcl-2 family proteins, which are known to have anti-apoptotic effects, were also examined. Staurosporine was used to induce apoptotic cell death in the MDCK cells. Staurosporine treatment was sufficient to induce apoptotic cell death, detected by propidium iodide and DNA ladder formation. A chloride-bicarbonate exchange blocker was added 24 h before the staurosporine treatment and during treatment. The chloride-bicarbonate exchange blocker inhibited the staurosporine-induced apoptosis in the MDCK cells in a dose-dependent manner. The expression of bcl-2 family gene products was detected by RT-PCR and Western blotting. No changes in the expression of Bax, Bid and Bik (pro-apoptotic proteins), or Bcl-2 (an anti-apoptotic protein) were detected. However, Mcl-1 expression was reduced by the staurosporine treatment, and this reduction was recovered when the chloride-bicarbonate exchange blocker was added. LY294002, a PI 3-kinase inhibitor, partially inhibited this anti-apoptotic effect. In conclusion, chloride-bicarbonate exchange blockers appear to offer cell-protective effects via Mcl-1 up-regulation.",
keywords = "4,4-diisothiocyanatostilbene-2,2-dislufonic acid (DIDS), Apoptosis, AVD, Mcl-1, PI 3-kinase, Staurosporine",
author = "Takashi Araki and Matsuhiko Hayashi and Naohide Watanabe and Hirotaka Kanuka and Jun Yoshino and Masayuki Miura and Takao Saruta",
year = "2002",
doi = "10.1006/bbrc.2002.6329",
language = "English",
volume = "290",
pages = "1275--1281",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "4",

}

TY - JOUR

T1 - Down-regulation of Mcl-1 by inhibition of the PI3-K/Akt pathway is required for cell shrinkage-dependent cell death

AU - Araki, Takashi

AU - Hayashi, Matsuhiko

AU - Watanabe, Naohide

AU - Kanuka, Hirotaka

AU - Yoshino, Jun

AU - Miura, Masayuki

AU - Saruta, Takao

PY - 2002

Y1 - 2002

N2 - The anti-apoptotic effect of a chloride-bicarbonate exchange blocker has been previously examined in endothelial cells and cardiomyocytes. However, the anti-apoptotic effects of this blocker on epithelial cells and the mechanism of the anti-apoptotic effect remain unknown. We examined the anti-apoptotic effects of a chloride-bicarbonate exchange blocker in a renal epithelial cell line (MDCK cells). Changes in the expression of bcl-2 family proteins, which are known to have anti-apoptotic effects, were also examined. Staurosporine was used to induce apoptotic cell death in the MDCK cells. Staurosporine treatment was sufficient to induce apoptotic cell death, detected by propidium iodide and DNA ladder formation. A chloride-bicarbonate exchange blocker was added 24 h before the staurosporine treatment and during treatment. The chloride-bicarbonate exchange blocker inhibited the staurosporine-induced apoptosis in the MDCK cells in a dose-dependent manner. The expression of bcl-2 family gene products was detected by RT-PCR and Western blotting. No changes in the expression of Bax, Bid and Bik (pro-apoptotic proteins), or Bcl-2 (an anti-apoptotic protein) were detected. However, Mcl-1 expression was reduced by the staurosporine treatment, and this reduction was recovered when the chloride-bicarbonate exchange blocker was added. LY294002, a PI 3-kinase inhibitor, partially inhibited this anti-apoptotic effect. In conclusion, chloride-bicarbonate exchange blockers appear to offer cell-protective effects via Mcl-1 up-regulation.

AB - The anti-apoptotic effect of a chloride-bicarbonate exchange blocker has been previously examined in endothelial cells and cardiomyocytes. However, the anti-apoptotic effects of this blocker on epithelial cells and the mechanism of the anti-apoptotic effect remain unknown. We examined the anti-apoptotic effects of a chloride-bicarbonate exchange blocker in a renal epithelial cell line (MDCK cells). Changes in the expression of bcl-2 family proteins, which are known to have anti-apoptotic effects, were also examined. Staurosporine was used to induce apoptotic cell death in the MDCK cells. Staurosporine treatment was sufficient to induce apoptotic cell death, detected by propidium iodide and DNA ladder formation. A chloride-bicarbonate exchange blocker was added 24 h before the staurosporine treatment and during treatment. The chloride-bicarbonate exchange blocker inhibited the staurosporine-induced apoptosis in the MDCK cells in a dose-dependent manner. The expression of bcl-2 family gene products was detected by RT-PCR and Western blotting. No changes in the expression of Bax, Bid and Bik (pro-apoptotic proteins), or Bcl-2 (an anti-apoptotic protein) were detected. However, Mcl-1 expression was reduced by the staurosporine treatment, and this reduction was recovered when the chloride-bicarbonate exchange blocker was added. LY294002, a PI 3-kinase inhibitor, partially inhibited this anti-apoptotic effect. In conclusion, chloride-bicarbonate exchange blockers appear to offer cell-protective effects via Mcl-1 up-regulation.

KW - 4,4-diisothiocyanatostilbene-2,2-dislufonic acid (DIDS)

KW - Apoptosis

KW - AVD

KW - Mcl-1

KW - PI 3-kinase

KW - Staurosporine

UR - http://www.scopus.com/inward/record.url?scp=0036289544&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036289544&partnerID=8YFLogxK

U2 - 10.1006/bbrc.2002.6329

DO - 10.1006/bbrc.2002.6329

M3 - Article

VL - 290

SP - 1275

EP - 1281

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 4

ER -